Healthgrades has released its annual ranking of the best hospitals in the U.S. for 2024, naming the 100 best hospitals in the nation and the top hospitals across 16 different medical specialties.
GI & Endoscopy
As colorectal cancer cases rise, gastroenterologists are pushing for patients to receive screenings, but some colonoscopy insurance loopholes stand in the way.
The use of fecal immunochemical testing as a screening tool for colorectal cancer is increasing.
As the gold standard for colon cancer, colonoscopies are often the subject of malpractice cases for gastroenterologists, according to a blog post from law firm Miller & Zois.
Lakewood, Colo.-based Rocky Mountain Gastroenterology has faced cyberattacks from at least three online criminal groups accessing the data of more than 169,000 patients, according to an Oct. 21 report from DataBreaches.net.
Advertisement
Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in Gastroenterology. The approach could significantly decrease the overall use of colonoscopies.
Some gastroenterologists have expressed concern over a lack of clarity in eligibility requirements in UnitedHealthcare's new gold card program, Gastroenterology & Endoscopy News reported Oct. 18.
Gastroenterology is seeing rapid changes, as colorectal cancer cases rise and the physician shortage intensifies.
Steven Brant, MD, professor at New Brunswick, N.J.-based Rutgers University, has been named the inaugural recipient of the Bishr and Souha Omary Family Endowed Legacy Professorship.
Although gastroenterologists are not common defendants in medical malpractice lawsuits, some cases over the last 10 years have resulted in multimillion-dollar settlements, according to a blog post from law firm Miller & Zois.